A Unified Platform for the Entire R&D Lifecycle
Paramanu unifies every stage of your generics R&D workflow into a single, intelligent platform.
Pre-Formulation Studies
Leverage AI to analyze API characteristics and excipient compatibility, predicting stability and performance to de-risk your development path.
Formulation Development
Intelligently design and optimize robust generic formulations with AI-driven DoE, achieving target product profiles faster than traditional methods.
Scale-Up & Tech Transfer
Employ AI simulations to model process parameters for scale-up, ensuring smooth technology transfer and consistent batch quality from lab to commercial production.
Bioequivalence & Clinicals
Streamline bioequivalence study design and data analysis with AI, enhancing the accuracy of statistical evaluation and reducing trial timelines.
Regulatory Submission
Automate the compilation of compliant ANDA/dossiers. Our AI helps check for data integrity and completeness, ensuring a smoother eCTD publishing process.
How We Turn Data into Discovery
Paramanu is built on core principles that turn your laboratory data into a strategic, predictive advantage.
We structure your disparate R&D data—unstructured notes, instrument data, and results—into an interconnected knowledge graph, revealing hidden relationships between experiments, compounds, and outcomes.
Paramanu's generative AI acts as a co-pilot, summarizing complex data, generating novel hypotheses from your results, and identifying unseen connections to accelerate discovery.
Built for Pharma Compliance
We take data security and regulatory compliance seriously. Your research is protected by industry-leading standards.
We are compliant with SOC 2 Type II standards, ensuring your data is handled securely.
All your data is encrypted in transit and at rest, providing maximum security.
Our platform is built to meet GxP and FDA 21 CFR Part 11 requirements for data integrity and electronic records.